SEMINOMA
Clinical trials for SEMINOMA explained in plain language.
Never miss a new study
Get alerted when new SEMINOMA trials appear
Sign up with your email to follow new studies for SEMINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Robot surgery could spare testicular cancer patients from chemo side effects
Disease control Recruiting nowThis study tests a robot-assisted surgery to remove lymph nodes in men with early-stage testicular cancer (seminoma) that has spread a little. The goal is to see if this approach can predict cancer return and reduce long-term side effects from chemotherapy. About 60 participants …
Matched conditions: SEMINOMA
Phase: PHASE2 • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Robot and dye could spare testicular cancer patients from unnecessary treatments
Diagnosis Recruiting nowThis study is testing a new, robot-assisted technique that uses a special dye to find if testicular cancer has spread to nearby lymph nodes. The goal is to see if this method is accurate enough (at least 90% sensitive) to replace current staging approaches. About 44 adults with e…
Matched conditions: SEMINOMA
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Diagnosis
Last updated Jun 10, 2026 13:26 UTC
-
Testicular cancer study: which treatment spares quality of life?
Symptom relief Recruiting nowThis study looks at how different treatments for testicular cancer affect quality of life. Men with good-prognosis metastatic testicular cancer will either have surgery (RPLND) or chemotherapy. The goal is to see which approach causes fewer side effects and better long-term well-…
Matched conditions: SEMINOMA
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Symptom relief
Last updated Jun 16, 2026 23:38 UTC
-
Testicular cancer patients needed for landmark treatment reduction study
Knowledge-focused Recruiting nowThis study is testing whether giving less treatment (de-escalation) to men with stage II seminoma testicular cancer is safe and improves quality of life. Researchers will enroll 30 men at two UK hospitals to see if patients are willing to join and how their cancer and well-being …
Matched conditions: SEMINOMA
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC